| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Zelicapavir | EDP-938; EP-023938 | Phase 2 Clinical | Enanta Pharmaceuticals Inc | Respiratory Syncytial Virus Infections | Details |
| PF-07923567 | RV-299; PF-07923567 | Phase 1 Clinical | Reviral Ltd | Respiratory Syncytial Virus Infections | Details |